The growth of the pain management market is primarily driven by increasing incidences of chronic illness including diabetic neuropathy, cancer, and osteoarthritis among others. Expanding the geriatric populace across geographies is another key factor that is likely to propel market growth during the review period. The rising number of surgical procedures due to increased accidental injuries is propelling the market growth substantially. In addition to this, increasing investment in research and development activities to develop novel drugs is likely to create lucrative opportunities for the players operating in the global market in the coming years.